Services
FUNDRAISING
M&A
LICENSING
STRATEGIC CONSULTING
Transactions
Team
News
Contact
SoniVie
SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System for Renal Artery Denervation
Show more
SoniVie Receives IDE Approval for its Pivotal Study for the TIVUS System to Treat Patients with Pulmonary Arterial Hypertension (PAH)
Show more
